Business Operations Contracts & Agreements in the Life Sciences Tools & Services Industry

310 Contracts & Agreements

Browse by Subcategory

Advisory Agreements (4 contracts from 4 companies)
Agency Agreements (14 | 7)
Collaboration Agreements (26 | 13)
Development Agreements (19 | 12)
Distribution Agreements (3 | 3)
Indemnification Agreements (53 | 41)
Management Agreements (18 | 7)
Marketing Agreements (4 | 3)
MOUs (6 | 1)
Proxy Agreements (1 | 1)
Sales Agreements (12 | 8)
Services Agreements (48 | 20)
Settlement Agreements (19 | 12)
Supply Agreements (63 | 14)
Termination Agreements (10 | 8)
Voting Agreements (10 | 5)

Browse by Company

Recent Contracts

Tenth Amendment to Manufacturing and Supply Agreement, dated as of January 1, 2025, by and between ChromaDex Inc. and W.R. Grace & Co.-Conn (ChromaDex Corp., Filed With SEC on October 31, 2024)
Advisory Agreement between Illumina, Inc. and Charles Dadswell, dated October 3, 2024 (Illumina Inc, Filed With SEC on October 3, 2024)
Manufacturing Services Agreement by and between the Registrant and Paramit Corporation, dated February 18, 2015 (BioNano Genomics, Inc, Filed With SEC on August 7, 2024)
Settlement and License Agreement, between Personalis, Inc. and Foresight Diagnostics, Inc., dated June 21, 2024 (Personalis, Inc., Filed With SEC on June 27, 2024)
Fourth Amendment to the Amended and Restated Supply and Commercialization Agreement, dated June 21, 2024, by and between Illumina, Inc. and GRAIL, LLC (Illumina Inc, Filed With SEC on June 24, 2024)
Plea Agreement, dated as of June 3, 2024, among Envigo RMS, LLC, Envigo Global Services, Inc., the United States Attorneys Office for the Western District of Virginia and the... (BIOANALYTICAL SYSTEMS INC, Filed With SEC on June 4, 2024)
Resolution Agreement, dated as of June 3, 2024, among Inotiv, Inc., Envigo RMS, LLC, Envigo Global Services, Inc., the United States Attorneys Office for the Western District of... (BIOANALYTICAL SYSTEMS INC, Filed With SEC on June 4, 2024)
Placement Agency Agreement, dated May 24, 2024, by and between the Company and Canaccord Genuity LLC (BioNano Genomics, Inc, Filed With SEC on May 28, 2024)
Form of Indemnification Agreement entered into by and between Standard BioTools Inc. and certain of its officers and directors (FLUIDIGM CORP, Filed With SEC on March 1, 2024)
Sales Agreement, dated as of February 28, 2024, between Nautilus Biotechnology, Inc. and Cowen and Company, LLC (ARYA Sciences Acquisition Corp III, Filed With SEC on February 28, 2024)
Third Amendment to Collaboration Agreement, dated September 21, 2023, among SomaLogic, Inc., Illumina Cambridge, Ltd., and Illumina, Inc (CM Life Sciences II Inc., Filed With SEC on November 8, 2023)
Third Amendment to Collaboration Agreement, dated as of October 27, 2023, by and between 23andMe, Inc. and GlaxoSmithKline Intellectual Property (No. 3) Limited (VG Acquisition Corp., Filed With SEC on November 8, 2023)
Ninth Amendment to Manufacturing and Supply Agreement, dated as of November 2, 2023, by and between ChromaDex Inc. and W.R. Grace & Co.-Conn (ChromaDex Corp., Filed With SEC on November 8, 2023)
First Amendment to the Amended and Restated Supply Agreement, dated August 16, 2023, by and between the Company, Nestec Ltd. and NHSc (ChromaDex Corp., Filed With SEC on November 8, 2023)
Form of Warrant Agency Agreement between SeqLL Inc. and Vstock Transfer LLC including form of warrant certificate (SeqLL, Inc., Filed With SEC on November 7, 2023)
Form of Warrant Agency Agreement between SeqLL Inc. and VStock Transfer LLC including form of warrant certificate (SeqLL, Inc., Filed With SEC on October 18, 2023)
Form of Warrant Agency Agreement between SeqLL Inc. and VStock Transfer LLC including form of warrant certificate (SeqLL, Inc., Filed With SEC on October 5, 2023)
Form of Warrant Agency Agreement between SeqLL Inc. and VStock Transfer LLC including form of warrant certificate (SeqLL, Inc., Filed With SEC on August 15, 2023)
Second Amendment to Supply Agreement, dated April 11, 2023, between SomaLogic, Inc. and Agilent Technologies, Inc (CM Life Sciences II Inc., Filed With SEC on August 14, 2023)
Second Amendment to Collaboration Agreement, dated June 15, 2023, among SomaLogic, Inc., Illumina Cambridge, Ltd. and Illumina, Inc (CM Life Sciences II Inc., Filed With SEC on June 22, 2023)
Sales Agreement, dated June 16, 2023, by and between Absci Corporation and Cowen and Company, LLC (AbSci Corp, Filed With SEC on June 16, 2023)
Amendment No. 1 to Sales Agreement, dated March 9, 2023, by and between the Company and Cowen and Company, LLC (BioNano Genomics, Inc, Filed With SEC on May 9, 2023)
Amendment No. 3 to the Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals (CODEXIS INC, Filed With SEC on May 4, 2023)
Settlement Agreement (Sotera Health Co, Filed With SEC on May 3, 2023)
First Amendment to Collaboration Agreement, dated November 14, 2022, among SomaLogic, Inc., Illumina Cambridge, Ltd. and Illumina, Inc (CM Life Sciences II Inc., Filed With SEC on March 28, 2023)
Protein Engineering Collaboration Agreement, dated as of March 13, 2023, by and between Quantum-Si Incorporated and Protein Evolution, Inc (HighCape Capital Acquisition Corp., Filed With SEC on March 17, 2023)
Advisory Agreement, dated as of November 1, 2022, by and between Quantum-Si Incorporated and Jonathan M. Rothberg, Ph.D (HighCape Capital Acquisition Corp., Filed With SEC on March 17, 2023)
Eighth Amendment to Manufacturing and Supply Agreement, dated as of December 14, 2022, by and between ChromaDex Inc. and W.R. Grace & Co.-Conn (ChromaDex Corp., Filed With SEC on March 8, 2023)
Form of Amendment to Senior Management Agreement (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on February 28, 2023)
Amendment No. 2 to the Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals, effective as of February 1, 2023 (CODEXIS INC, Filed With SEC on February 27, 2023)
Amendment No. 1 to the Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals, effective as of December 19, 2022 (CODEXIS INC, Filed With SEC on February 27, 2023)
Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals, dated as of July 14, 2022 (CODEXIS INC, Filed With SEC on February 27, 2023)
Form of Indemnification Agreement between the Company and each of its directors, officers and certain employees (CODEXIS INC, Filed With SEC on February 27, 2023)
Placement Agency Agreement dated as of February 13, 2023 between SeqLL Inc. and Maxim Group LLC (SeqLL, Inc., Filed With SEC on February 15, 2023)
Amendment No. 2 to Master Collaboration Agreement, dated as of January 4, 2023, by and between SomaLogic Operating Co., Inc. and Novartis Pharma AG (CM Life Sciences II Inc., Filed With SEC on January 10, 2023)
Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals (CODEXIS INC, Filed With SEC on November 4, 2022)
Termination and Release Agreement (ChromaDex Corp., Filed With SEC on October 3, 2022)
Amended and Restated Development and Commercialization Agreement by and between the Registrant and Invitae Corporation dated June 24, 2022 (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on August 8, 2022)
Form of Indemnification and Advancement Agreement (Syneos Health, Filed With SEC on August 2, 2022)
Settlement Agreement, dated as of July 11, 2022, by and between Inivata Limited and Clive Morris (NEOGENOMICS INC, Filed With SEC on July 18, 2022)